| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81.3M | +10.7% | +32.6% |
| Cost of Revenue | $34.7M | +11.4% | +46.0% |
| Gross Profit | $46.6M | +10.2% | +24.2% |
| R&D Expense | $27.3M | +13.1% | +8.4% |
| SG&A Expense | $18.8M | +1.7% | +3.9% |
| Operating Income | -$18.3M | -2.1% | +18.9% |
| Pre-tax Income | -$58.4M | -164.3% | -191.2% |
| Income Tax | $784K | +57.7% | +3036.0% |
| Net Income | -$59.2M | -162.0% | -194.7% |
| EPS (Basic) | -$0.19 | -171.4% | -171.4% |
| EPS (Diluted) | -$0.19 | -171.4% | -171.4% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $443.3M | +144.8% | +219.0% |
| Accounts Receivable | $46.3M | -10.3% | +19.2% |
| Current Assets | $754.1M | +112.2% | +150.1% |
| Total Assets | $1.11B | +58.8% | +75.4% |
| Current Liabilities | $188.6M | -7.3% | +46.1% |
| Total Liabilities | $756.5M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $113.7M | — | — |
| Capital Expenditures | $55.1M | — | — |
| Investing Cash Flow | -$188.7M | — | — |
| Financing Cash Flow | $388.1M | — | — |
| Free Cash Flow | $58.6M | — | — |
| +355.3% |
| Stockholders' Equity | $349.6M | -19.8% | -24.8% |